| scholarly article | Q13442814 |
| P2093 | author name string | Rajiv Kumar | |
| G Mike Makrigiorgos | |||
| Wilfred Ngwa | |||
| Piotr Zygmanski | |||
| Srinivas Sridhar | |||
| Ross Berbeco | |||
| Robert A Cormack | |||
| Houari Korideck | |||
| P2860 | cites work | In vivo tumor targeting and spectroscopic detection with surface-enhanced Raman nanoparticle tags | Q40031376 |
| Nanomedicine: nanocarriers shape up for long life | Q40066554 | ||
| Elucidating the mechanism of cellular uptake and removal of protein-coated gold nanoparticles of different sizes and shapes. | Q40139914 | ||
| Peptide-labeled near-infrared quantum dots for imaging tumor vasculature in living subjects | Q40293849 | ||
| Antiangiogenic properties of gold nanoparticles | Q40427876 | ||
| Kinetics of vascular normalization by VEGFR2 blockade governs brain tumor response to radiation: role of oxygenation, angiopoietin-1, and matrix metalloproteinases. | Q40479307 | ||
| The use of gold nanoparticles to enhance radiotherapy in mice | Q40499366 | ||
| Intravenous transferrin, RGD peptide and dual-targeted nanoparticles enhance anti-VEGF intraceptor gene delivery to laser-induced CNV. | Q41442716 | ||
| The Role of Surface Functionality on Acute Cytotoxicity, ROS Generation and DNA Damage by Cationic Gold Nanoparticles | Q41642723 | ||
| Third generation gold nanoplatform optimized for radiation therapy | Q41829461 | ||
| In vitro radiosensitization by gold nanoparticles during continuous low-dose-rate gamma irradiation with I-125 brachytherapy seeds. | Q41829627 | ||
| Patient-reported quality of life after salvage brachytherapy for radio-recurrent prostate cancer: A prospective Phase II study | Q41848137 | ||
| DNA damage enhancement from gold nanoparticles for clinical MV photon beams | Q42011166 | ||
| Intravenously administered gold nanoparticles pass through the blood-retinal barrier depending on the particle size, and induce no retinal toxicity | Q43239219 | ||
| Flurbiprofen-loaded stealth liposomes: studies on the development, characterization, pharmacokinetics, and biodistribution | Q43246889 | ||
| Cellular radiation dosimetry and its implications for estimation of radiation risks. Illustrative results with technetium 99m-labeled microspheres and macroaggregates | Q43957801 | ||
| Nanoscience and nanotechnology: evolving definitions and growing footprint on the scientific landscape | Q44262085 | ||
| Long-term failure patterns and survival in a randomized dose-escalation trial for prostate cancer. Who dies of disease? | Q44772974 | ||
| Applying gold nanoparticles as tumor-vascular disrupting agents during brachytherapy: estimation of endothelial dose enhancement | Q44786631 | ||
| Impact of beam quality on megavoltage radiotherapy treatment techniques utilizing gold nanoparticles for dose enhancement. | Q44900411 | ||
| The management of respiratory motion in radiation oncology report of AAPM Task Group 76. | Q44924583 | ||
| Enhanced macromolecule diffusion deep in tumors after enzymatic digestion of extracellular matrix collagen and its associated proteoglycan decorin | Q44989902 | ||
| Kilovoltage stereotactic radiosurgery for age-related macular degeneration: assessment of optic nerve dose and patient effective dose | Q45173238 | ||
| Gold nanoparticles enhance the radiation therapy of a murine squamous cell carcinoma | Q45213619 | ||
| An eight-year experience of HDR brachytherapy boost for localized prostate cancer: biopsy and PSA outcome. | Q45248416 | ||
| CCR3 is a target for age-related macular degeneration diagnosis and therapy | Q24338258 | ||
| The dosimetric feasibility of gold nanoparticle-aided radiation therapy (GNRT) via brachytherapy using low-energy gamma-/x-ray sources | Q24632315 | ||
| Global data on visual impairment in the year 2002 | Q24650312 | ||
| Gold nanoparticles as novel agents for cancer therapy | Q27008020 | ||
| Multifunctional nanoparticles: cost versus benefit of adding targeting and imaging capabilities | Q27011598 | ||
| A new concept for macromolecular therapeutics in cancer chemotherapy: mechanism of tumoritropic accumulation of proteins and the antitumor agent smancs | Q28285226 | ||
| Radiotherapy enhancement with gold nanoparticles | Q28288052 | ||
| Utilizing targeted gene therapy with nanoparticles binding alpha v beta 3 for imaging and treating choroidal neovascularization | Q28740612 | ||
| Normalization of tumor vasculature: an emerging concept in antiangiogenic therapy | Q29547379 | ||
| Determining the size and shape dependence of gold nanoparticle uptake into mammalian cells | Q29615461 | ||
| Ranibizumab for neovascular age-related macular degeneration | Q29617549 | ||
| Designer nanoparticles: incorporating size, shape and triggered release into nanoscale drug carriers. | Q30476027 | ||
| Acute and late complications after radiotherapy for prostate cancer: results of a multicenter randomized trial comparing 68 Gy to 78 Gy. | Q31151905 | ||
| Effective targeting of solid tumors in patients with locally advanced cancers by radiolabeled pegylated liposomes. | Q32107154 | ||
| Biocompatibility of gold nanoparticles and their endocytotic fate inside the cellular compartment: a microscopic overview | Q33226381 | ||
| Update of Dutch multicenter dose-escalation trial of radiotherapy for localized prostate cancer | Q33336936 | ||
| Intravascular delivery of particulate systems: does geometry really matter? | Q33361339 | ||
| Influence of anchoring ligands and particle size on the colloidal stability and in vivo biodistribution of polyethylene glycol-coated gold nanoparticles in tumor-xenografted mice | Q33398443 | ||
| Nuclear targeting of gold nanoparticles in cancer cells induces DNA damage, causing cytokinesis arrest and apoptosis | Q33525128 | ||
| Dose escalation and quality of life in patients with localized prostate cancer treated with radiotherapy: long-term results of the Dutch randomized dose-escalation trial (CKTO 96-10 trial). | Q33565184 | ||
| Near infrared light-triggered drug generation and release from gold nanoparticle carriers for photodynamic therapy | Q33578775 | ||
| Mechanism of active targeting in solid tumors with transferrin-containing gold nanoparticles | Q33666994 | ||
| Estimation of microscopic dose enhancement factor around gold nanoparticles by Monte Carlo calculations | Q33689742 | ||
| Intratumoral delivery of beta-lapachone via polymer implants for prostate cancer therapy | Q33753357 | ||
| 16-Gy low-voltage x-ray irradiation followed by as-needed ranibizumab therapy for AMD: 6-month outcomes of a "radiation-first" strategy | Q33989238 | ||
| 16-Gy low-voltage x-ray irradiation with ranibizumab therapy for AMD: 6-month safety and functional outcomes | Q33989248 | ||
| Locally recurrent prostate cancer after external beam radiation therapy: diagnostic performance of 1.5-T endorectal MR imaging and MR spectroscopic imaging for detection | Q34017719 | ||
| 24-Gy low-voltage x-ray irradiation with ranibizumab therapy for neovascular AMD: 6-month safety and functional outcomes. | Q34129730 | ||
| The potential of nanomedicine therapies to treat neovascular disease in the retina. | Q34220590 | ||
| Challenges and key considerations of the enhanced permeability and retention effect for nanomedicine drug delivery in oncology | Q34328650 | ||
| Assessment of targeting accuracy of a low-energy stereotactic radiosurgery treatment for age-related macular degeneration | Q34402842 | ||
| Targeting angiogenesis, the underlying disorder in neovascular age-related macular degeneration | Q34425420 | ||
| Cell-specific targeting of nanoparticles by multivalent attachment of small molecules | Q34462201 | ||
| Cell-Specific Radiosensitization by Gold Nanoparticles at Megavoltage Radiation Energies | Q34462887 | ||
| Radiation therapy for neovascular age-related macular degeneration | Q34548686 | ||
| Multistage nanoparticle delivery system for deep penetration into tumor tissue | Q34572820 | ||
| Gold nanoparticles are taken up by human cells but do not cause acute cytotoxicity | Q34595551 | ||
| Ranibizumab combined with verteporfin photodynamic therapy in neovascular age-related macular degeneration: year 1 results of the FOCUS Study. | Q34653066 | ||
| Selective targeting of brain tumors with gold nanoparticle-induced radiosensitization | Q34701455 | ||
| Delivering nanomedicine to solid tumors | Q34726981 | ||
| A perspective on vascular disrupting agents that interact with tubulin: preclinical tumor imaging and biological assessment | Q34765364 | ||
| Prostate cancer-specific survival following salvage radiotherapy vs observation in men with biochemical recurrence after radical prostatectomy | Q34794205 | ||
| Ranibizumab versus verteporfin photodynamic therapy for neovascular age-related macular degeneration: Two-year results of the ANCHOR study | Q34913612 | ||
| Targeting the tumor blood vessel network to enhance the efficacy of radiation therapy | Q35042096 | ||
| Infrared-transparent gold nanoparticles converted by tumors to infrared absorbers cure tumors in mice by photothermal therapy | Q35092823 | ||
| Brachytherapy for recurrent prostate cancer after radiation therapy | Q35120294 | ||
| Photodynamic therapy for age-related macular degeneration in a clinical setting: visual results and angiographic patterns | Q35666861 | ||
| Salvage brachytherapy after external-beam irradiation for prostate cancer. | Q35685340 | ||
| Making polymeric micro- and nanoparticles of complex shapes | Q35901299 | ||
| Size-dependent localization and penetration of ultrasmall gold nanoparticles in cancer cells, multicellular spheroids, and tumors in vivo | Q36017657 | ||
| Endothelial cell proliferation as a novel approach to targeting tumour therapy | Q36046291 | ||
| Role of salvage radical prostatectomy for recurrent prostate cancer after radiation therapy | Q36309694 | ||
| pHLIP peptide targets nanogold particles to tumors | Q36535248 | ||
| Nanoparticle location and material dependent dose enhancement in X-ray radiation therapy | Q36584987 | ||
| The effect of flattening filter free delivery on endothelial dose enhancement with gold nanoparticles | Q36648953 | ||
| Drug insight: vascular disrupting agents and angiogenesis--novel approaches for drug delivery | Q36670473 | ||
| Intensity modulating and other radiation therapy devices for dose painting | Q36756945 | ||
| Particle shape: a new design parameter for micro- and nanoscale drug delivery carriers | Q36838213 | ||
| Gold nanoparticle imaging and radiotherapy of brain tumors in mice | Q36853281 | ||
| Management of prostate cancer recurrences after radiation therapy-brachytherapy as a salvage option | Q36904756 | ||
| Patient selection, cancer control, and complications after salvage local therapy for postradiation prostate-specific antigen failure: a systematic review of the literature | Q36908600 | ||
| Normal tissue reactions to radiotherapy: towards tailoring treatment dose by genotype | Q37162103 | ||
| Multifunctional magnetic nanoparticles for targeted imaging and therapy | Q37174947 | ||
| Triple therapy for neovascular age-related macular degeneration using single-session photodynamic therapy combined with intravitreal bevacizumab and triamcinolone | Q37186846 | ||
| Shape effects of filaments versus spherical particles in flow and drug delivery | Q37338776 | ||
| Strategies for biologic image-guided dose escalation: a review | Q37392536 | ||
| Targeted gold nanoparticles enable molecular CT imaging of cancer | Q37409530 | ||
| Vascular disrupting agents: a novel mechanism of action in the battle against non-small cell lung cancer | Q37497826 | ||
| Gold-loaded polymeric micelles for computed tomography-guided radiation therapy treatment and radiosensitization | Q37532295 | ||
| Antiangiogenic approaches to age-related macular degeneration today | Q37607658 | ||
| Nanoparticles for improved therapeutics and imaging in cancer therapy. | Q37771341 | ||
| Intracellular uptake, transport, and processing of gold nanostructures. | Q37798554 | ||
| Strategies to improve radiotherapy with targeted drugs | Q37856721 | ||
| Biogenic gold nanoparticles: As a potential candidate for brain tumor directed drug delivery | Q38192664 | ||
| Enhanced relative biological effectiveness of proton radiotherapy in tumor cells with internalized gold nanoparticles | Q38366112 | ||
| Gold nanoparticle-aided brachytherapy with vascular dose painting: estimation of dose enhancement to the tumor endothelial cell nucleus | Q38435105 | ||
| Radiosensitizer-eluting nanocoatings on gold fiducials for biologicalin-situimage-guided radio therapy (BIS-IGRT) | Q38442840 | ||
| Biological in situ dose painting for image-guided radiation therapy using drug-loaded implantable devices | Q38448133 | ||
| Drug-loaded gold plasmonic nanoparticles for treatment of multidrug resistance in cancer. | Q39042860 | ||
| Photoactivation of gold nanoparticles for glioma treatment | Q39156510 | ||
| Enhanced proton treatment in mouse tumors through proton irradiated nanoradiator effects on metallic nanoparticles | Q39234538 | ||
| Dependence of Monte Carlo microdosimetric computations on the simulation geometry of gold nanoparticles. | Q39324477 | ||
| Biogenic gold nanoparticles as fotillas to fire berberine hydrochloride using folic acid as molecular road map. | Q39336184 | ||
| Targeted gold nanoparticles enable molecular CT imaging of cancer: an in vivo study | Q39395788 | ||
| The influence of size, shape and vessel geometry on nanoparticle distribution | Q39428932 | ||
| Evaluation of cytotoxicity and radiation enhancement using 1.9 nm gold particles: potential application for cancer therapy | Q39684409 | ||
| Preferential tumour accumulation of gold nanoparticles, visualised by Magnetic Resonance Imaging: radiosensitisation studies in vivo and in vitro. | Q39687243 | ||
| The pattern of prostate cancer local recurrence after radiation and salvage cryoablation | Q39718325 | ||
| Gold nanoparticles for the improved anticancer drug delivery of the active component of oxaliplatin | Q39728421 | ||
| Enhancement of cell radiation sensitivity by pegylated gold nanoparticles. | Q39749727 | ||
| Gold nanoparticle sensitize radiotherapy of prostate cancer cells by regulation of the cell cycle | Q39808184 | ||
| Mediating tumor targeting efficiency of nanoparticles through design | Q39864411 | ||
| Enhancement of radiation cytotoxicity in breast-cancer cells by localized attachment of gold nanoparticles | Q39949337 | ||
| Importance of the liposomal cationic lipid content and type in tumor vascular targeting: physicochemical characterization and in vitro studies using human primary and transformed endothelial cells | Q39956311 | ||
| Enhancement of radiation effects by gold nanoparticles for superficial radiation therapy. | Q39975675 | ||
| Parameters governing gold nanoparticle X-ray radiosensitization of DNA in solution | Q39982631 | ||
| Imaging epidermal growth factor receptor expression in vivo: pharmacokinetic and biodistribution characterization of a bioconjugated quantum dot nanoprobe | Q40017269 | ||
| Gold nanoparticles of diameter 1.4 nm trigger necrosis by oxidative stress and mitochondrial damage. | Q45916200 | ||
| Bioaccumulation and toxicity of gold nanoparticles after repeated administration in mice | Q46535897 | ||
| Gold nanoparticles: a new X-ray contrast agent | Q46960636 | ||
| Size-dependent radiosensitization of PEG-coated gold nanoparticles for cancer radiation therapy. | Q47304949 | ||
| Implications on clinical scenario of gold nanoparticle radiosensitization in regards to photon energy, nanoparticle size, concentration and location | Q47367623 | ||
| Assessing the effect of surface chemistry on gold nanorod uptake, toxicity, and gene expression in mammalian cells | Q48025543 | ||
| Dosimetric consequences of intrafraction prostate motion | Q48891096 | ||
| Influence of intrafraction motion on margins for prostate radiotherapy | Q48936951 | ||
| Effects of the vascular disrupting agent ZD6126 on interstitial fluid pressure and cell survival in tumors | Q50116234 | ||
| Fabrication and characterization of controlled release poly(D,L-lactide-co-glycolide) millirods. | Q50506105 | ||
| Stereotactic low-voltage x-ray irradiation for age-related macular degeneration. | Q50695186 | ||
| The calculation of dose enhancement close to platinum implants for skull radiography. | Q50915263 | ||
| The adhesive strength of non-spherical particles mediated by specific interactions. | Q51174053 | ||
| Localized dose enhancement to tumor blood vessel endothelial cells via megavoltage X-rays and targeted gold nanoparticles: new potential for external beam radiotherapy. | Q51624320 | ||
| Potential improvements in the therapeutic ratio of prostate cancer irradiation: dose escalation of pathologically identified tumour nodules using intensity modulated radiotherapy. | Q52044715 | ||
| Gold nanoparticle enhancement of stereotactic radiosurgery for neovascular age-related macular degeneration. | Q53140889 | ||
| Stereotactic radiosurgery for AMD: a Monte Carlo-based assessment of patient-specific tissue doses. | Q53260326 | ||
| Long-term results of conformal radiotherapy for prostate cancer: impact of dose escalation on biochemical tumor control and distant metastases-free survival outcomes. | Q53549211 | ||
| Sphingosine-1-phosphate protects proliferating endothelial cells from ceramide-induced apoptosis but not from DNA damage-induced mitotic death. | Q53570400 | ||
| Treatment failure after primary and salvage therapy for prostate cancer: likelihood, patterns of care, and outcomes. | Q54290701 | ||
| Radiation oncology: a century of achievements. | Q55038981 | ||
| Monte Carlo simulation of microbeam radiation therapy with an interlaced irradiation geometry and an Au contrast agent in a realistic head phantom | Q56933336 | ||
| Gold Nanoparticles as Radiation Sensitizers in Cancer Therapy | Q59382376 | ||
| Dendrimer-based targeted intravitreal therapy for sustained attenuation of neuroinflammation in retinal degeneration | Q61865891 | ||
| Irradiation of gold nanoparticles by x-rays: Monte Carlo simulation of dose enhancements and the spatial properties of the secondary electrons production | Q61902152 | ||
| Radiosensitization of DNA by gold nanoparticles irradiated with high-energy electrons | Q64387707 | ||
| The presence of a concomitant bulky tumor can decrease the uptake and therapeutic efficacy of radiolabeled antibodies in small tumors | Q68135095 | ||
| Inhomogeneous deposition of radiopharmaceuticals at the cellular level: experimental evidence and dosimetric implications | Q68884404 | ||
| Vascular Endothelium as the Vulnerable Element in Tumours | Q72749467 | ||
| Gold microspheres: a selective technique for producing biologically effective dose enhancement | Q73139073 | ||
| Real-time vital optical imaging of precancer using anti-epidermal growth factor receptor antibodies conjugated to gold nanoparticles | Q73344148 | ||
| Tumor response to radiotherapy regulated by endothelial cell apoptosis | Q73401346 | ||
| It is not time to abandon radiotherapy for neovascular age-related macular degeneration | Q73437491 | ||
| Role of extracellular matrix assembly in interstitial transport in solid tumors | Q73793048 | ||
| Prostate cancer radiotherapy dose response: an update of the fox chase experience | Q75435977 | ||
| Locally advanced prostatic cancer: long-term toxicity outcome after three-dimensional conformal radiation therapy--a dose-escalation study | Q77401846 | ||
| Increased apoptotic potential and dose-enhancing effect of gold nanoparticles in combination with single-dose clinical electron beams on tumor-bearing mice | Q81078170 | ||
| Characterization of the theorectical radiation dose enhancement from nanoparticles | Q81314428 | ||
| Long-term outcome and toxicity of salvage brachytherapy for local failure after initial radiotherapy for prostate cancer | Q82814129 | ||
| Promise of new vascular-disrupting agents balanced with cardiac toxicity: is it time for oncologists to get to know their cardiologists? | Q83019266 | ||
| Significant reduction of normal tissue dose by proton radiotherapy compared with three-dimensional conformal or intensity-modulated radiation therapy in Stage I or Stage III non-small-cell lung cancer | Q83304061 | ||
| Generation of reactive oxygen species induced by gold nanoparticles under x-ray and UV Irradiations | Q83443712 | ||
| Quantifying tumor-selective radiation dose enhancements using gold nanoparticles: a monte carlo simulation study | Q83693929 | ||
| A Monte Carlo study on tissue dose enhancement in brachytherapy: a comparison between gadolinium and gold nanoparticles | Q84381453 | ||
| Contrast-enhanced radiotherapy: feasibility and characteristics of the physical absorbed dose distribution for deep-seated tumors | Q84452155 | ||
| Beam energy considerations for gold nano-particle enhanced radiation treatment | Q84611761 | ||
| An x-ray fluorescence imaging system for gold nanoparticle detection | Q86564184 | ||
| P433 | issue | 7 | |
| P921 | main subject | adaptive radiation therapy | Q180507 |
| nanoparticle | Q61231 | ||
| P304 | page(s) | 1063-1082 | |
| P577 | publication date | 2014-05-01 | |
| P1433 | published in | Nanomedicine | Q15817508 |
| P1476 | title | Targeted radiotherapy with gold nanoparticles: current status and future perspectives | |
| P478 | volume | 9 |
| Q50922065 | A Monte Carlo study of I-125 prostate brachytherapy with gold nanoparticles: dose enhancement with simultaneous rectal dose sparing via radiation shielding. |
| Q35686257 | A Plasmonic Gold Nanostar Theranostic Probe for In Vivo Tumor Imaging and Photothermal Therapy |
| Q38406535 | A Software App for Radiotherapy with In-situ Dose-painting using high Z nanoparticles |
| Q38837229 | AGuIX nanoparticles as a promising platform for image-guided radiation therapy |
| Q92136656 | Anti-cancer effects of chemotherapeutic agent; 17-AAG, in combined with gold nanoparticles and irradiation in human colorectal cancer cells |
| Q58231809 | Bulbous gold–carbon nanodot hybrid nanoclusters for cancer therapy |
| Q38742241 | Cellular Uptake of Gold Nanoparticles and Their Behavior as Labels for Localization Microscopy. |
| Q64275109 | Challenges and Contradictions of Metal Nano-Particle Applications for Radio-Sensitivity Enhancement in Cancer Therapy |
| Q39191184 | Challenges and Prospects for Providing Radiation Oncology Services in Africa |
| Q92444845 | Delivery of Nanoparticle-Based Radiosensitizers for Radiotherapy Applications |
| Q57492232 | Determination of dose enhancement caused by AuNPs with Xoft Axxent Electronic (eBx™) and conventional brachytherapy: in vitro study |
| Q48218239 | Dose enhancement effects of gold nanoparticles specifically targeting RNA in breast cancer cells |
| Q92864492 | Dosimetry and Radioenhancement Comparison of Gold Nanoparticles in Kilovoltage and Megavoltage Radiotherapy using MAGAT Polymer Gel Dosimeter |
| Q39393466 | Emerging Nanotechnology and Advanced Materials for Cancer Radiation Therapy. |
| Q89005900 | Energy optimization in gold nanoparticle enhanced radiation therapy |
| Q38727923 | Enhancing radiotherapy for lung cancer using immunoadjuvants delivered in situ from new design radiotherapy biomaterials: a preclinical study. |
| Q50524925 | Evaluation of spectral photon counting computed tomography K-edge imaging for determination of gold nanoparticle biodistribution in vivo. |
| Q64251956 | Femtosecond Spectroscopy of Au Hot-Electron Injection into TiO₂: Evidence for Au/TiO₂ Plasmon Photocatalysis by Bactericidal Au Ions and Related Phenomena |
| Q33602008 | Functional Gene Analysis Reveals Cell Cycle Changes and Inflammation in Endothelial Cells Irradiated with a Single X-ray Dose |
| Q59128247 | Gold Nanoparticle Mediated Phototherapy for Cancer |
| Q41475959 | Gold nanoparticles enhance anti-tumor effect of radiotherapy to hypoxic tumor. |
| Q90002752 | In vivo evaluation of safety, biodistribution and pharmacokinetics of laser-synthesized gold nanoparticles |
| Q36803774 | Kilovoltage radiosurgery with gold nanoparticles for neovascular age-related macular degeneration (AMD): a Monte Carlo evaluation. |
| Q51031719 | Low-Dose Prostate Cancer Brachytherapy with Radioactive Palladium-Gold Nanoparticles. |
| Q53113375 | Multiphoton Microscopy of Nonfluorescent Nanoparticles In Vitro and In Vivo. |
| Q42156032 | Nanoparticle Drones to Target Lung Cancer with Radiosensitizers and Cannabinoids |
| Q38831572 | Nanoparticle Mediated Tumor Vascular Disruption: A Novel Strategy in Radiation Therapy |
| Q42212265 | Nanoparticle-aided external beam radiotherapy leveraging the Čerenkov effect. |
| Q38661115 | Nanoscale radiation transport and clinical beam modeling for gold nanoparticle dose enhanced radiotherapy (GNPT) using X-rays |
| Q55346844 | Octaarginine-modified gold nanoparticles enhance the radiosensitivity of human colorectal cancer cell line LS180 to megavoltage radiation. |
| Q89818181 | Optimizing a Novel Au-Grafted Lipid Nanoparticle Through Chelation Chemistry for High Photothermal Biologic Activity |
| Q36003550 | Photo-thermal effect enhances the efficiency of radiotherapy using Arg-Gly-Asp peptides-conjugated gold nanorods that target αvβ3 in melanoma cancer cells |
| Q37098720 | Potential for enhancing external beam radiotherapy for lung cancer using high-Z nanoparticles administered via inhalation |
| Q37108646 | Potential of using cerium oxide nanoparticles for protecting healthy tissue during accelerated partial breast irradiation (APBI). |
| Q92906894 | Radiation as an In Situ Auto-Vaccination: Current Perspectives and Challenges |
| Q47714803 | Signal enhancement due to high-Z nanofilm electrodes in parallel plate ionization chambers with variable microgaps |
| Q39105322 | Smart Radiation Therapy Biomaterials |
| Q90254050 | Systemic immune effects boost radiotherapy |
| Q37097954 | Targeted radiotherapy enhancement during electronic brachytherapy of accelerated partial breast irradiation (APBI) using controlled release of gold nanoparticles |
| Q28610710 | Technology for Innovation in Radiation Oncology |
| Q89550903 | TiO2 Nanomaterials Non-Controlled Contamination Could Be Hazardous for Normal Cells Located in the Field of Radiotherapy |
| Q38759409 | Titanium peroxide nanoparticles enhanced cytotoxic effects of X-ray irradiation against pancreatic cancer model through reactive oxygen species generation in vitro and in vivo. |
| Q49958115 | Using immunotherapy to boost the abscopal effect |
Search more.